Enhancing ultrasound-mediated cell membrane permeabilisation (sonoporation) using a high frequency pulse regime and implications for ultrasound-aided cancer chemotherapy

Cancer Letters

Volumn 266, Issue 2, 2008, Pages 156-162

  Li, Ying Suet ^a   Reid, Cherith N ^a   McHale, Anthony P ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Chemotherapeutic; Frequency; Pulse; Sonoporation; Ultrasound

Indexed keywords

CAMPTOTHECIN; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; SONOVUE;

ARTICLE; CANCER CHEMOTHERAPY; CELL MEMBRANE PERMEABILITY; CELL POPULATION; CELL VIABILITY; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; LD 50; MICROBUBBLE; PRIORITY JOURNAL; ULTRASOUND;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CELL MEMBRANE PERMEABILITY; COMBINED MODALITY THERAPY; DEXTRANS; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; HELA CELLS; HUMANS; NEOPLASMS; ULTRASONICS;

EID: 45049086717     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.02.041     Document Type: Article

References (14)

1. Wu F., ter Haar G., and Chen W.R. High-intensity focused ultrasound ablation of breast cancer. Expert Rev. Anticancer Ther. 7 (2007) 823-831
2. Wharton I.P., Rivens I.H., ter Haar G.R., Gilderdale D.J., Collins D.J., Hand J.W., Abel P.D., and deSouza N.M. Design and development of a prototype endocavitary probe for high-intensity focused ultrasound delivery with integrated magnetic resonance imaging. J. Magn. Reson. Imaging 25 (2007) 548-556
3. Pilepich M.V., Jones K.G., Emami B.N., Perez C.A., Fields J.N., and Myerson R.J. Interaction of Bleomycin and hyperthermia - results of a clinical pilot study. Int. J. Radiat. Oncol. Biol. Physiol. 16 (1989) 211-213
4. Saad A., and Hahn G. Ultrasound-enhanced effects of adriamycin against murine tumours. Ultrasound Med. Biol. 18 (1992) 715-723
5. Tachibana K., Uchida T., Tamura K., Eguchi H., Yamashita N., and Ogawa K. Enhanced cytotoxic effect of Ara-C by low intensity ultrasound to HL-60 cells. Cancer Lett. 149 (2000) 189-194
6. Liang H.D., Lu Q.L., Xue S.A., Halliwell M., Kodama T., Cosgrove D.O., Stauss H.J., Partridge T.A., and Blomley M.J.K. Optimisation of ultrasound-mediated gene transfer (sonoporation) in skeletal muscle cells. Ultrasound Med. Biol. 30 (2004) 1523-1529
7. Bull J.L. The application of microbubbles for targeted drug delivery. Expert Opin. Drug Del. 4 (2007) 475-493
8. Duvshani-Eshet M., Adam D., and Machluf M. The effects of albumin-coated microbubbles in DNA delivery mediated by therapeutic ultrasound. J. Control. Release 112 (2006) 156-166
9. Li T., Tachibana K., Kuroki M., and Kuroki M. Gene transfer with echo contrast agents: comparison between Albunex, Optison and Levovist in mice - initial results. Radiology 229 (2003) 423-428
10. Iwanaga K., Tominaga K., Yamamoto K., Habu M., Maeda H., Akifusa S., Tsujisawa T., Okinaga T., Fukuda J., and Nishihara T. Local delivery system of cytotoxic to tumours by focused sonoporation. Cancer Gene Ther. 14 (2007) 354-363
11. Boa S., Thrall B.D., and Miller D.L. Transfection of a reporter plasmid into cultured cells by sonoporation in vitro. Ultrasound Med. Biol. 23 (1997) 953-959
12. Kinoshita M., and Hynynen K. Key factors that effect sonoporation efficiency in in vitro settings: the importance of standing wave in sonoporation. Biochem. Biophys. Res. Comm. 359 (2007) 860-865
13. Yoshikawa M., Ikegami Y., Hayasaka S., Ishii K., Ito A., Sano K., Suzuki T., Togawa T., Yoshida H., Soda H., Oka M., Kohno S., Sawada S., Ishikawa T., and Tanabe S. Novel camptothecin analogues that circumvent ABCG2-associated drug resistance in human tumour cells. Int. J. Cancer 110 (2004) 921-927
14. Yu D., Peng P., Dharap S.S., Wang Y., Mehlig M., Chandna P., Zhoa H., Filpula D., Yang K., Borowski V., Borchard G., Zhang Z., and Minko T. Antitumor activity of poly(ethylene glycol)-camptothecin conjugate: the inhibition of tumour growth in vivo. J. Control. Release 110 (2005) 90-102